Eversense CGM System

Senseonics launches the Eversense Bridge Program in the U.S.

The company's implantable system is the only long-term CGM that lasts up to 90 days; it is now available for $99 plus the cost of the sensor placement.
eversense

Senseonics, TypeZero and Roche Diabetes Care team-up to trial a long-term artificial pancreas system

The trial will integrate Senseonics' Eversense CGM System with TypeZero's inControl AP algorithms and Roche's Accu-Chek Insight Insulin Pump.
Senseonics - Eversense CGM System

Senseonics’ Eversense CGM System receives CE Mark approval

The system includes an implanted glucose sensor that lasts up to 90 days, a wearable smart transmitter to calculate glucose levels, and a mobile app.
Senseonics

Senseonics, Diasend working on integrated continuous glucose data management solution

The two companies aim to enable clinicians and patients to use the Diasend solution to review past CGM data along with insulin pump and activity tracker data.
sensor finger

Senseonics looking to raise $51.75M in an IPO

The company has developed a pill-sized sensor that is entirely implanted in the user's upper arm from where it can continuously monitor their glucose levels.
Senseonics CGM

Senseonics raises $10M for its implanted CGM sensor

The company makes a pill-like sensor that is entirely implanted in the user's upper arm from where it can continuously monitor glucose levels.
Senseonics

Senseonics raises additional $20 million of private equity financing, gets a new VP of...

The company will use the fresh cash to complete pivotal trials in Europe, obtaining CE mark, and initiate IDE trials in the United States.